---
document_datetime: 2023-09-21 17:21:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ultratard-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: ultratard-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 0.8148905
conversion_datetime: 2025-12-19 00:41:31.138897
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Procedural steps taken and scientific information after the authorisation

<!-- image -->

| No      | Scope                                                                                                                                                                                        | Opinion issued on   | Commission Decision Issued/ amended on   | Product Information affected 2   | Summary   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|------------------------------------------|----------------------------------|-----------|
| II/0002 | Change(s) to container                                                                                                                                                                       | 25/09/2003          | 01/10/2003                               |                                  |           |
| II/0001 | Change(s) to the manufacturing process for the active substance Change(s) to the test method(s) and/or specifications for the active substance Change(s) to shelf-life or storage conditions | 25/09/2003          | 01/10/2003                               |                                  |           |

2 SPC (Summary of Product Characteristics), Labelling, PL (Package Leaflet)

Medicinal Product no longer authorised Changes made after 01/11/2002 Ultratard MAJOR CHANGES 1 MINOR CHANGES 3 There have been no minor changes. 1 Major changes e.g. Type II variations, Annex II applications, Renewals and Annual Reassessments

3 Minor changes e.g. Type I variations and Notifications